Linked Data API

Show Search Form

Search Results

1505163
registered interest false more like this
date less than 2022-09-05more like thismore than 2022-09-05
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Tixagevimab/cilgavimab more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, when he expects NICE's review of Evusheld to be concluded. more like this
tabling member constituency North Durham more like this
tabling member printed
Mr Kevan Jones more like this
uin 47379 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-09-20more like thismore than 2022-09-20
answer text <p>On 10 August 2022, the Department referred tixagevimab and cilgavimab (Evusheld) to the National Institute for Health and Care Excellence (NICE) to evaluate its clinical and cost effectiveness for preventing COVID-19. Between 29 July and 12 August, NICE consulted with stakeholders on the suggested remit, draft scope and list of consultees and commentators.</p><p>NICE has commenced this evaluation and currently expects to publish draft guidance in April 2023, with final guidance to follow in May 2023. In discussion with AstraZeneca, NICE is expediting the appraisal process by bringing forward the deadline for the manufacturer’s evidence submission.</p> more like this
answering member constituency Newark remove filter
answering member printed Robert Jenrick more like this
question first answered
remove filter
answering member
4320
label Biography information for Robert Jenrick more like this
previous answer version
17716
answering member constituency Suffolk Coastal more like this
answering member printed Dr Thérèse Coffey more like this
answering member 4098
tabling member
1438
label Biography information for Mr Kevan Jones more like this